WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsMolson Coors Brewing Co Class B (TAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 155% more annual revenue ($28.43B vs $11.14B). MDLN leads profitability with a 4.1% profit margin vs -19.2%. MDLN earns a higher WallStSmart Score of 52/100 (C-).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

TAP

Hold

44

out of 100

Grade: D

Growth: 4.7Profit: 4.0Value: 4.0Quality: 5.0
Piotroski: 4/9Altman Z: 0.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.67

$24.25 discount

UndervaluedFair: $66.92Overvalued

Intrinsic value data unavailable for TAP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

TAP1 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

TAP4 concerns · Avg: 2.0/10
PEG RatioValuation
4.112/10

Expensive relative to growth rate

Return on EquityProfitability
-18.2%2/10

ROE of -18.2% — below average capital efficiency

Revenue GrowthGrowth
-2.7%2/10

Revenue declined 2.7%

EPS GrowthGrowth
-12.5%2/10

Earnings declined 12.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : TAP

The strongest argument for TAP centers on Price/Book.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : TAP

The primary concerns for TAP are PEG Ratio, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

MDLN profiles as a value stock while TAP is a turnaround play — different risk/reward profiles.

MDLN is growing revenue faster at 14.8% — sustainability is the question.

TAP generates stronger free cash flow (358M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLN scores higher overall (52/100 vs 44/100) and 14.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Molson Coors Brewing Co Class B

CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA

The Molson Coors Beverage Company, commonly known as Molson Coors, is a multinational drink and brewing company headquartered in Chicago in the United States.

Visit Website →

Want to dig deeper into these stocks?